p53 inhibition of GLS promotes glutamine's use for biosynthetic processes like nucleotide production, preventing excess -KG production in specific cellular contexts
Giorgi Pkhakadze, MD, MPH, PhD GMJ News Desk Strong Evidence The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the first oral glucagon-like peptide-1 (GLP-1) receptor agonist pill for weight loss, marking a significant advancement in obesity treatment accessibility
Be alert to warning signs requiring higher levels of care, including suicidal thoughts, severe depression, significant dehydration, electrolyte abnormalities, or medical instability
Not consuming enough protein can lead to loss of lean body mass, weakness, edema, hair loss, and skin changes